Schizophrenia is a complex mental health disorder with positive, negative and cognitive symptom domains. Approximately one third of patients are resistant to currently available medication. New therapeutic targets and a better understanding of the basic biological processes that drive pathogenesis are needed in order to develop therapies that will improve qu...
Therapeutic advances in psychopharmacology
2015-01-31
Steeds H, Carhart-Harris RL, Stone JM
PubMed Published
psilocybin AddictionReview ArticleDrug Interactions Review Article LSDPCP
Hallucinogens have been part of spiritual practice for millennia, but controversy surrounding their mind-manifesting effects led to their proscription by the mid-20th century, largely without evidence of harm or toxicity and despite nascent data suggesting therapeutic utility in treating depressive illnesses. This review explores their pharmacodynamic action...
Therapeutic advances in psychopharmacology
2014-07-31
Baumeister D, Barnes G, Giaroli G, Tracy D
PubMed Published
psilocybin DepressionAnxietyPharmacologyMechanism of ActionReceptor PharmacologyConsciousnessSpiritualityClinical TrialReview ArticleSafetyToxicity Clinical Trial 5-HT2ALSD
Hallucinogen-based interventions may benefit substance use populations, but contemporary data informing the impact of hallucinogens on addictive behavior are scarce. Given that many individuals in the criminal justice system engage in problematic patterns of substance use, hallucinogen treatments also may benefit criminal justice populations. However, the re...
Journal of psychopharmacology (Oxford, England)
2013-12-31
Hendricks PS, Clark CB, Johnson MW, Fontaine KR, Cropsey KL
PubMed Published
psilocybin Addiction Other Hallucinogencriminal justice
Internal medicine journal
2012-10-31
Lim TH, Wasywich CA, Ruygrok PN
PubMed Published
psilocybin General Other
In 2007, the Minister of Health of the Netherlands requested the CAM (Coordination point Assessment and Monitoring new drugs) to assess the overall risk of magic mushrooms. The present paper is an updated redraft of the review, written to support the assessment by CAM experts. It summarizes the literature on physical or psychological dependence, acute and ch...
Regulatory toxicology and pharmacology: RTP
2011-03-31
van Amsterdam J, Opperhuizen A, van den Brink W
PubMed Published
psilocybin Review ArticleSafetyToxicityAbuse Liability Review Article
Two topics, related to mushroom poisoning of recent interest in Japan, have been presented. In autumn 2004, 59 cases of acute encephalopathy were reported across 9 prefectures in Japan (24 from Akita Prefecture with 8 deaths; age 48-93, average 70; female 14, male 10). Of 24 cases, 20 had kidney dysfunction. Four poisoned subjects showed no kidney trouble. O...
Chudoku kenkyu: Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology
2009-02-28
Gonmori K, Yokoyama K
PubMed Published
psilocybin Headache / MigraineConsciousness Other
A28-year-old man with a history of drug and alcohol abuse presented multiple times to the hospital over 2 months with an elusive constellation of symptoms, resolving spontaneously in each instance. This patient required a high level of care for management and stabilization, including 3 emergency department visits, 2 medical floor admissions, and 1 intensive ...
The American journal of emergency medicine
2008-09-30
McClintock RL, Watts DJ, Melanson S
PubMed Published
psilocybin Brain ImagingAgingToxicity Other
A survey of magic mushroom use was completed by 174 participants in 2004, a year when the sale of hallucinogenic mushrooms was not illegal in the UK. The data were collected in Edinburgh and Bristol (UK). Participants were a self-selecting convenience sample. Participants tended to be in their 20s, White-British, in education or employed; 64% were male. Part...
Substance use & misuse
2007-12-31
Riley SC, Blackman G
PubMed Published
psilocybin AnxietyObservational Study Observational Study
We report the case of a 25-year-old, hepatitis C-infected man, who presented with severe rhabdomyolysis and acute renal failure, and later developed posterior encephalopathy with cortical blindness after the ingestion of magic mushrooms. Conventional respiratory and cardiovascular support including mechanical ventilation, continuous veno-venous hemodialysis ...
European journal of emergency medicine: official journal of the European Society for Emergency Medicine
2005-11-30
Bickel M, Ditting T, Watz H, Roesler A, Weidauer S, Jacobi V, Gueller S, Betz C, Fichtlscherer S, Stein J
PubMed Published
psilocybin Adverse Events Other
Accurate and sensitive analytical methods for psilocin (PC) and psilocybin (PB), tryptamine-type hallucinogens contained in "magic mushrooms," were investigated using liquid chromatography-mass spectrometry (LC-MS) and liquid chromatography-tandem mass spectrometry (LC-MS-MS). The chromatographic separation on an ODS column and mass spectral information gave...
Journal of forensic sciences
2005-02-28
Kamata T, Nishikawa M, Katagi M, Tsuchihashi H
PubMed Published
psilocybinpsilocin General Other
To assess the reliability of drug use reports by young respondents, this study examined the extent of recanting previous drug use reports within an ongoing longitudinal survey of adolescent drug use. Here, recanting was defined as a positive report of life-time drug use that was subsequently denied 1 year later. The covariates of recanting were also studied....
Addiction (Abingdon, England)
2005-01-31
Percy A, McAlister S, Higgins K, McCrystal P, Thornton M
PubMed Published
psilocybin AddictionObservational StudyAdolescents Observational Study
In the past 10 years from 1991 to 2000, the number of consultations to the Japan Poison Information Center were 947 concerning mushroom poisonings. However, those from the hospital cases were not analyzed toxicologically. We examined toxicologically 20 cases (35 patients) of mushroom poisonings from 1993 to 2001. Investigation of amanita toxin poisoning was ...
Legal medicine (Tokyo, Japan)
2003-02-28
Gonmori K, Yoshioka N
PubMed Published
psilocybin General Other
Pharmacokinetic studies of psilocybin in humans have shown the rapid dephosphorylation of psilocybin to psilocin with further conversion to 4-hydroxy-tryptophole (4HT) and 4-hydroxyindole-3-acetic acid (4HIAA) in plasma. Our study shows that psilocin also undergoes conjugation and can be found in the urine as the psilocin-glucuronide conjugate. Recoveries af...
Journal of forensic sciences
2001-04-30
Grieshaber AF, Moore KA, Levine B
PubMed Published
psilocybinpsilocin Pharmacology Other
To determine the characteristics of pregnant women who use Ecstasy (3,4-methylenedioxymethamphetamine, MDMA), and to identify reproductive risk factors associated with this group of women. Prospective, observational study. Pregnant women who have contacted the Motherisk Alcohol and Substance Use Helpline at The Hospital for Sick Children, in Toronto, about e...
Neurotoxicology and teratology
2000-12-31
Ho E, Karimi-Tabesh L, Koren G
PubMed Published
psilocybin AddictionEmotional ProcessingObservational StudySafety Observational Study
Journal of neurology
2000-02-29
Spengos K, Schwartz A, Hennerici M
PubMed Published
psilocybin General Other
The Veterinary record
1990-12-14
Jones J
PubMed Published
psilocybin General Other
The Veterinary record
1990-02-09
Kirwan AP
PubMed Published
psilocybin General Other
A method has been developed for the rapid isolation and identification of psilocin from psilocin/psilocybin-containing mushrooms. Based on the difference in the solubility properties in butyl chloride of psilocin and other constituents present in psilocin/psilocybin-containing mushrooms, psilocin was easily separated in pure form.
Journal of forensic sciences
1985-06-30
Lee RE
PubMed Published
psilocybinpsilocin General Other
A simple aqueous extraction method for the isolation and identification of psilocin from Psilocybe cubensis mushrooms is reported. This method employs a dephosphorylation of the phosphate ester to psilocin, which facilitates a greater product yield and simplifies identification. Psilocin extracted by this method is sufficiently concentrated and free of cocon...
Journal of forensic sciences
1984-12-31
Casale JF
PubMed Published
psilocin General Other
The clinical features are reported in 27 cases of ‘magic mushroom’ ingestion. Mydriasis and hyperreflexia were common as were disorders of perception and affect. appears to have been the species of fungus involved.
Postgraduate medical journal
1981-08-31
Peden NR, Bissett AF, Macaulay KE, Crooks J, Pelosi AJ
PubMed Published
psilocybin Toxicity Other